Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous tumor-draining lymph node-derived lymphocytes

A preparation of autologous lymphocytes that are isolated from each patient's tumor-draining lymph nodes and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous tumor-draining LNLs specifically recognize and kill the patient's tumor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	autologous TdLN-derived lymphocytes autologous tumor-draining LNLs

autologous tumor-draining lymph node-derived lymphocytes

Search NCI's Drug Dictionary